Journal of Neuro-Ophthalmology - JNO Podcast Series

Recent reports show that varicella zoster virus (VZV) antigen is found in temporal artery (TA) biopsies in patients with giant cell arteritis (GCA). Two experts (Drs Liao and Kedar) debate whether anti-viral therapy should be used routinely in patients with GCA.

In this podcast, the author of the paper entitled “More Than Meets the Eye: The Eye and Migraine—What You Need to Know” discusses how the migraine and eye pain pathways are similar and affect many of the common complaints which are seen in ophthalmology and neuro-ophthalmology offices, such as dry eye and postoperative eye pain.

In tjis podcast Dr Paul Phillips discusses findings from his paper with Janet Rucker “Efferent Vision Therapy”. They conclude there is insufficient evidence to recommend “vision therapy” for the treatment of learning disabilities, impaired reading, dyslexia, or ADHD.

In this podcast, the authors of the paper entitled “Neuro-ophthalmology of space flight” provide an update of the history, clinical findings, and possible pathogenic etiologies of the constellation of neuro-ophthalmic findings discovered in astronauts after long-duration space flight; and to discuss the terrestrial implications of such findings.

This podcast features an interview with Caroline Tilikete, author of a recent JNO State of the Art Review on Ocular Motor Manifestations of Multiple Sclerosis. The high prevalence of ocular motor manifestations emphasizes the importance of neuro-ophthalmological examination among patients with MS. Appropriate treatment, which both the paper and podcast explore, may improve visual outcome in some of these ocular motor disorders.

In this podcast, the authors of “Cerebellar Control of Eye Movements” discuss the central role the cerebellum plays in the real-time controland long-term modulation of eye movements.

In this podcast, Dr Neil Miller,one of the authors of the editorial entitled “A Nonarteritic Anterior Ischemic Optic Neuropathy Clinical Trial: An Industry and NORDIC Collaboration” talks about what is the leading cause of sudden optic nerve–related vision loss in individuals over 50 years old (caused by inadequate blood supply to the optic nerve head). Dr Miller discusses QRK207. QRK207 will be the first trial to use a potential neuroprotective therapy delivered early to reduce permanent injury and lessen the vision loss from acute NAION.